Sapient Capital LLC Takes Position in American Well Co. (NYSE:AMWL)

Sapient Capital LLC purchased a new stake in American Well Co. (NYSE:AMWL) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 165,888 shares of the company’s stock, valued at approximately $247,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. GSA Capital Partners LLP boosted its holdings in American Well by 75.5% in the 3rd quarter. GSA Capital Partners LLP now owns 716,830 shares of the company’s stock valued at $839,000 after purchasing an additional 308,418 shares during the last quarter. Versor Investments LP acquired a new position in American Well in the third quarter valued at approximately $294,000. Quadrature Capital Ltd purchased a new position in American Well in the third quarter worth approximately $36,000. Barclays PLC increased its stake in American Well by 8.8% during the third quarter. Barclays PLC now owns 173,359 shares of the company’s stock worth $203,000 after acquiring an additional 14,021 shares during the last quarter. Finally, Swiss National Bank raised its position in American Well by 2.3% in the third quarter. Swiss National Bank now owns 463,200 shares of the company’s stock valued at $542,000 after purchasing an additional 10,500 shares during the period. Institutional investors and hedge funds own 56.05% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on AMWL. Needham & Company LLC reissued a “hold” rating on shares of American Well in a research report on Thursday, May 2nd. Morgan Stanley lowered their price objective on shares of American Well from $1.75 to $1.00 and set an “equal weight” rating for the company in a research report on Monday, April 15th.

American Well Price Performance

Shares of American Well stock opened at $0.56 on Wednesday. The stock has a market capitalization of $161.52 million, a price-to-earnings ratio of -0.45 and a beta of 1.12. American Well Co. has a 12 month low of $0.45 and a 12 month high of $2.74. The business has a 50-day moving average of $0.77 and a 200 day moving average of $1.06.

American Well (NYSE:AMWL) last announced its earnings results on Wednesday, May 1st. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.07). American Well had a negative return on equity of 46.76% and a negative net margin of 137.32%. The business had revenue of $59.52 million for the quarter, compared to analysts’ expectations of $61.10 million. During the same period in the previous year, the company earned ($0.24) earnings per share. Equities research analysts anticipate that American Well Co. will post -0.72 earnings per share for the current year.

Insider Activity

In related news, EVP Vukasin Paunovich sold 251,323 shares of the business’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $1.09, for a total transaction of $273,942.07. Following the completion of the transaction, the executive vice president now directly owns 2,535,635 shares of the company’s stock, valued at approximately $2,763,842.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, EVP Vukasin Paunovich sold 251,323 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $1.09, for a total value of $273,942.07. Following the sale, the executive vice president now owns 2,535,635 shares of the company’s stock, valued at $2,763,842.15. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Kathy Johnson Weiler sold 283,192 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $1.09, for a total transaction of $308,679.28. Following the transaction, the insider now owns 3,975,617 shares of the company’s stock, valued at approximately $4,333,422.53. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,168,915 shares of company stock worth $1,261,161. Corporate insiders own 12.94% of the company’s stock.

About American Well

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.